CETOACIDOSIS DIABETICA ADA 2009 PDF

NCBI Bookshelf. Endotext [Internet]. Adair R Gosmanov , M. Diabetic ketoacidosis DKA and hyperglycemic hyperosmolar state HHS are acute metabolic complications of diabetes mellitus that can occur in patients with both type 1 and 2 diabetes mellitus. Timely diagnosis, comprehensive clinical and biochemical evaluation, and effective management is key to the successful resolution of DKA and HHS.

Author:Doushicage Vohn
Country:India
Language:English (Spanish)
Genre:Life
Published (Last):2 April 2007
Pages:204
PDF File Size:6.95 Mb
ePub File Size:4.61 Mb
ISBN:994-5-35086-651-7
Downloads:61961
Price:Free* [*Free Regsitration Required]
Uploader:Brakazahn



Chubb SP. Clin Biochem Rev. Feb ;30 1 —8. Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Endocr Pract. American Diabetes Association. Medical Management of Type 1 Diabetes. Management of Type 2 Diabetes.

Intensive Diabetes Management. Standards of Medical Care in Diabetes— Diab Care. Standards of Medical Care in Diabetes January ;35 1 :S Diab Care ;36 1 :S Transition From Intravenous to Subcutaneous Insulin Effectiveness and safety of a standardized protocol and predictors of outcome in patients with acute coronary syndrome.

Jul ;34 7 — Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Treatment of inpatient hyperglycemia beginning in the emergency department: a randomized trial using insulins aspart and detemir compared with usual care. J Hosp Med. Bianchi C, Del Prato S. Rev Diabet Stud. Blackwell SC. Counterpoint: enough evidence to treat? The American College of Obstetricians and Gynecologists guidelines. Clin Chem. Jul ; 56 7 Breithaupt T.

Postoperative glycemic control in cardiac surgery patients. Proc Bayl Univ Med Cent. Diagnosis and management of hyperglycemic emergencies. Hormones Athens. Controversies in management of diabetes from preconception to the postnatal period. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U. Cryer PE.

Diverse causes of hypoglycemia associated autonomic failure in diabetes. Evaluation of glycemic control following discontinuation of an intensive insulin protocol. Devos PJ, Melot C. Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glucontrol study. Intensive Care Med. Dhar GC. Intensive glycemic control. Can Fam Physician. Assessing the value of diabetes education. Diabetes Educ. Duncan AE. Hyperglycemia and Perioperative Glucose Management.

Curr Pharm Des. Treatment outcome and prognostic indices in patients with hyperglycemic emergencies. Diabetes Metab Syndr Obes. Intensive versus conventional glucose control in critically ill patients.

Glucose control and mortality in critically ill patients. Evaluation of hyponatremia: a little physiology goes a long way.

Cleve Clin J Med. August ; 71 8 Fluid Management in Diabetic Ketoacidosis. Are We Adhering to Recommended Guidelines? Br J Diabetes Vasc Dis. Furnary AP. Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy. Am J Cardiol.

New strategies for glucose control in patients with type 1 and type 2 diabetes mellitus in pregnancy. Clin Obstet Gynecol. American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm consensus statement--executive summary. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Genuth S, Bennett P. Follow-up report on the diagnosis of diabetes mellitus. Long-term effects of intensive glucose lowering on cardiovascular outcomes.

Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study. Acta Diabetol. Dutch guideline for the management of electrolyte disorders — revision. The Netherlands Journal of Medicine. April ;71 3 Inzucchi SA. Management of Hyperglycemia in the Hospital Setting. Inzucchi SE, Siegel D. Inzucchi SE. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

Kavanagh BP. September ; 13 J Clin Endocrinol Metab. May ;93 5 — Hyperglycemic crises in adult patients with diabetes. Kragelund Nielsen K, Kapur A. The urgent need for universally applicable simple screening procedures and diagnostic criteria for gestational diabetes mellitus — lessons from projects funded by the World Diabetes Foundation.

Glob Health Action. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. Algorithm for the treatment of type 2 diabetes: a position statement of Brazilian Diabetes Society.

Hanefeld M, Bramlage P. Curr Diab Rep. Meier M. Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies. Vasc Health Risk Manag.

AS DUAS BABILONIAS ALEXANDER HISLOP PDF

2015, Número 2

Chubb SP. Clin Biochem Rev. Feb ;30 1 —8. Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Endocr Pract.

BODY LANGUAGE FOR DUMMIES BY ELIZABETH KUHNKE PDF

insulina basal para el manejo de cetoacidosis diabetica 2018.pdf

Descubra todo lo que Scribd tiene para ofrecer, incluyendo libros y audiolibros de importantes editoriales. European Journal of Internal Medicine. Article history: Due to its pharmacokinetic properties, it has been suggested that long-acting insulin analogues may have a role in Received 2 June facilitating the transition from continuous intravenous insulin infusion to subcutaneous maintenance therapy in Received in revised form 20 July patients with DKA for prevention of rebound hyperglycemia, particularly if there are high insulin requirements. Accepted 27 August Concomitant administration of basal insulin analogues with regular insulin infusion accelerates ketoacidosis res- Available online 31 August olution and prevents rebound hyperglycemia. Keywords: Several studies have investigated the use of basal insulin in the management of DKA. Studies have been instituted Diabetic ketoacidosis on pediatric patients and adult patients. Long-acting basal insulin analogues These studies reveal that co-administration of basal insulin in combination with an insulin infusion in the acute management of DKA is feasible.

Related Articles